According to data published by Precedence Research, the global in-vitro diagnostics (IVD), diagnostic instruments, and biosensors ecosystem demonstrates sustained long-term expansion, driven by rising ...

On July 31, 2014, the U.S. Food and Drug Administration ("FDA") announced plans to regulate laboratory developed tests ("LDTs"). In this Client Alert, we explore FDA's proposed regulatory framework ...

Every person who has received blood test results or been treated in a hospital has benefited from in vitro diagnostic testing. The prevalence of these tests and their direct influence on the next ...

FDA’s Final Rule regulating Laboratory-Developed Tests (LDTs) has been published in the Federal Register yesterday, May 6, 2024. This follows a decades-long effort by some stakeholders to clarify the ...

The reagents were rigorously evaluated and independently certified through My Green Lab’s comprehensive assessment process. This globally recognized standard provides transparent, third-party verified ...

SAN DIEGO, Aug. 3, 2017 /PRNewswire/ -- Opioid addiction and other drugs of abuse, blood poisoning and crippling diseases driving up healthcare costs and threatening outcomes, were problems taken on ...

Join us in a timely two-day event on advancing diagnostic immunoassay technology and performance. During this Virtual IVD Conference, March 16-17, 2021, starting at 8:00am EDT, we will be discussing ...

The chemical supplier Alfa Chemistry has recently introduced three IVD products for laboratory use, adding to its already diverse range of biological reagents. NY ...

MINNEAPOLIS, March 23, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed its clinical validation of an in vitro ...

Making an in vitro diagnostic assay has never been easy. Now with the global lab and supply chain and disruptions caused by the COVID pandemic, the development and manufacture of IVDs faces further ...